Literature DB >> 20186472

Measurement conditions for flow cytometry analyses of cell lines from urological carcinomas.

Angelika Tölle1, Ziyad Abdallah, Klaus Jung, Hans Bäumler.   

Abstract

Prerequisites for successful flow cytometry investigations are specific antibodies labeled with appropriate fluorochromes and negligible autofluorescence of the untreated cells at the wavelength of interest. The aim of this study was (a) to characterize frequently used urological carcinoma cell lines with regard to their autofluorescence properties, (b) to demonstrate the autofluorescence as a serious interfering factor on FACS analysis of urological carcinoma cell lines and (c) to suggest an alternative to avoid interfering autofluorescence. Twenty-one cell lines originating from prostate carcinoma, renal cell carcinoma and bladder cancer were included in this study. The various cell lines were read on a flow cytometer in comparison to human erythrocytes as cells with low fluorescence intensity. Urological cell lines show a high autofluorescence when flow cytometry analyses are performed at the frequently used excitation wavelengths at 405 and 488 nm. At excitation wavelength of 633 nm, this problem was reduced and most of the cell lines (14/21) were without autofluorescence at the emission wavelength of 785 nm. In addition, with a spectrofluorometer three exemplary cell lysates were investigated. The above observations were confirmed. The dye APC-Cy7 is one suitable fluorochrome for successful investigation under these measurement conditions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20186472     DOI: 10.1007/s10895-010-0621-5

Source DB:  PubMed          Journal:  J Fluoresc        ISSN: 1053-0509            Impact factor:   2.217


  22 in total

1.  A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles.

Authors:  Pratip K Chattopadhyay; Joanne Yu; Mario Roederer
Journal:  Nat Med       Date:  2005-09-25       Impact factor: 53.440

2.  Changes in fluorescence intensity of selected leukocyte surface markers following fixation.

Authors:  Judith C Stewart; Michelle L Villasmil; Mark W Frampton
Journal:  Cytometry A       Date:  2007-06       Impact factor: 4.355

Review 3.  Basic science for the practicing physician: flow cytometry and cell sorting.

Authors:  Marla Moloney; Wayne G Shreffler
Journal:  Ann Allergy Asthma Immunol       Date:  2008-11       Impact factor: 6.347

4.  Photodynamic cystoscopy for detection of bladder tumors.

Authors:  M Kriegmair; D Zaak; R Knuechel; R Baumgartner; A Hofstetter
Journal:  Semin Laparosc Surg       Date:  1999-06

Review 5.  Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy.

Authors:  C D Jennings; K A Foon
Journal:  Blood       Date:  1997-10-15       Impact factor: 22.113

6.  Identification of mitochondria-rich cells in unstained vital preparations of epithelia by autofluorescence.

Authors:  M Köhler; E Frömter
Journal:  Pflugers Arch       Date:  1985-01       Impact factor: 3.657

7.  Electrophoretic and aggregation behavior of bovine, horse and human red blood cells in plasma and in polymer solutions.

Authors:  H Bäumler; B Neu; R Mitlöhner; R Georgieva; H J Meiselman; H Kiesewetter
Journal:  Biorheology       Date:  2001       Impact factor: 1.875

8.  Correlation between autofluorescence intensity and tumor area in mice bearing renal cell carcinoma.

Authors:  Maria Helena Bellini; Enia Lúcia Coutinho; Lilia Coronato Courrol; Flávia Rodrigues de Oliveira Silva; Nilson Dias Vieira Júnior; Nestor Schor
Journal:  J Fluoresc       Date:  2008-05-17       Impact factor: 2.217

9.  Role of 5-aminolevulinic acid in the detection of urothelial premalignant lesions.

Authors:  Dirk Zaak; Edwin Hungerhuber; Peter Schneede; Herbert Stepp; Dominic Frimberger; Stefan Corvin; Nikolaus Schmeller; Martin Kriegmair; Alfons Hofstetter; Ruth Knuechel; Ruth Knöchel
Journal:  Cancer       Date:  2002-09-15       Impact factor: 6.860

10.  Endogenous porphyrin fluorescence in tumors.

Authors:  D M Harris; J Werkhaven
Journal:  Lasers Surg Med       Date:  1987       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.